Tests magnetic stimulation of the cerebellum to aid thinking after stroke
Tests repetitive magnetic stimulation of the cerebellum in adults with thinking problems after stroke.
Key facts
- Who runs it
- Zi-Xiao Li
- Where
- Beijing, ChinaSee the site
- Trial code
- Registry title
- HOPE From the Cerebellum: TMS-Induced Cognitive Recovery After Stroke
- Status
- Recruiting
- People taking part
- 70 people, planned
- Started
- 1 Jan 2025
- Expected to end
- 1 Apr 2027
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- iTBS group
- control group
- Record updated
- 2 July 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who had an ischemic stroke within the last 2 weeks and have problems with thinking and memory. It tests magnetic stimulation of the cerebellum.
- Age
- 18 years or older
- Sex
- All sexes can join.
- Disease stage
- First ischemic stroke within 2 weeks, with a MoCA score below 26.
Main reasons for not taking part
- Bleeding in the brain or around the brain (cerebral or subarachnoid hemorrhage)
- A history of epilepsy before the stroke
The registry criteria, word for word
Show all 2 criteriaShow less
Who can take part
- (1)ischemic stroke, with an initial incident occurring within 2 weeks;(2)MoCA<26
Who cannot take part
- (1)Cerebral hemorrhage or subarachnoid hemorrhage;(2)A pre-existing history of epilepsy
Where in China
- Beijing Tiantan HospitalBeijing, ChinaContact: Weili JiaTaking people
About the trial
What the trial wants to find out
The objective of this clinical trial is to investigate the effectiveness and safety of repetitive transcranial magnetic stimulation (rTMS) in the cerebellum for individuals with post-stroke cognitive impairment. Participants will undergo rTMS in the cerebellar hemisphere opposite the lesion site, once daily for a total of five days.
The 2 groups in the trial
- iTBS groupTreatment being tested
iTBS on the contralesional cerebellum
- control groupPlacebo, for comparison
shame stimulation on the contralesional cerebellum
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- HOPE From the Cerebellum: TMS-Induced Cognitive Recovery After Stroke
- Plain-language title
- Tests magnetic stimulation of the cerebellum to aid thinking after strokeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 2 July 2025